NCT04959591

Brief Summary

The purpose of this study is to investigate whether perioperative intravenous acetaminophen administration reduces postoperative pain and opioid consumption in adolescents and pediatric patients undergoing spinal fusion surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jun 2021

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 28, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 13, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2022

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2022

Completed
Last Updated

December 28, 2022

Status Verified

December 1, 2022

Enrollment Period

11 months

First QC Date

June 28, 2021

Last Update Submit

December 27, 2022

Conditions

Keywords

scoliosis, acetaminophen

Outcome Measures

Primary Outcomes (1)

  • Postoperative analgesic consumption

    Comparison of total analgesic consumption between 3 groups in morphine equivalent

    24 hours after surgery

Secondary Outcomes (6)

  • Postoperative analgesic consumption

    48 hours after surgery

  • Post operative pain scores

    4, 8, 24, 48 hours after surgery

  • Frequency of side effects of opioids

    24, 48, 72 hours after surgery

  • Quality of recovery questionaire

    3 to 5 days after surgery

  • Postoperative recovery

    from end of surgery to discharge from hospitalization (average 7 days)

  • +1 more secondary outcomes

Study Arms (3)

Experimental (Pre): Acetaminophen

EXPERIMENTAL

Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg after anesthetic induction/before surgical incision and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given at the end of surgery before skin closure.

Drug: intravenous acetaminophen

Experimental(post): Acetaminophen

EXPERIMENTAL

Participants will receive 15mg/kg intravenous acetaminophen 15mg/kg at the end of surgery before skin closure and the same dose will be given postoperatively at 8 hour intervals for 24hours. A single dose of placebo (saline) will also be given after anesthetic induction/before surgical incision.

Drug: intravenous acetaminophen

Placebo comparator : placebo

PLACEBO COMPARATOR

Participants will receive 1.5ml/kg placebo (0.9% saline) before and after surgery and the same dose will be given postoperatively at 8hour intervals for 24hours.

Drug: Placebo

Interventions

experimental(pre): administration of IV acetaminophen

Experimental (Pre): Acetaminophen

placebo comparator: administration of normal saline

Placebo comparator : placebo

Eligibility Criteria

Age11 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status 1-3
  • patients undergoing spinal fusion surgery

You may not qualify if:

  • patients who refuse to participate in this study
  • patients unable to communicate due to mental impairment or developmental delay
  • patients allergic to acetaminophen or its additives or who are contraindicated in acetaminophen administration for other reasons
  • patients with existing liver diseases or dysfunction (i.e. active hepatitis, clinically relevant chronic liver conditions, elevated liver enzymes)
  • patients who are judged ineligible by the medical staff to participate in the study for other reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asan Medical Center

Seoul, 05505, South Korea

Location

Related Publications (4)

  • Shastri N. Intravenous acetaminophen use in pediatrics. Pediatr Emerg Care. 2015 Jun;31(6):444-8; quiz 449-50. doi: 10.1097/PEC.0000000000000463.

    PMID: 26035501BACKGROUND
  • Wick EC, Grant MC, Wu CL. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017 Jul 1;152(7):691-697. doi: 10.1001/jamasurg.2017.0898.

    PMID: 28564673BACKGROUND
  • Ceelie I, de Wildt SN, van Dijk M, van den Berg MM, van den Bosch GE, Duivenvoorden HJ, de Leeuw TG, Mathot R, Knibbe CA, Tibboel D. Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA. 2013 Jan 9;309(2):149-54. doi: 10.1001/jama.2012.148050.

    PMID: 23299606BACKGROUND
  • Kim YJ, Kim HJ, Kim S, Kim H, Lee CS, Hwang CJ, Cho JH, Ro YJ, Koh WU. Comparison of preemptive and preventive intravenous acetaminophen on opioid consumption in pediatrics undergoing posterior spinal fusion surgery: a randomized controlled trial. Korean J Anesthesiol. 2024 Jun;77(3):326-334. doi: 10.4097/kja.23747. Epub 2024 Feb 20.

MeSH Terms

Conditions

Scoliosis

Condition Hierarchy (Ancestors)

Spinal CurvaturesSpinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Won Uk Koh, M.D, Ph.D

    Asan Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The designated research pharmacist will prepare the both study drug (IV acetaminophen) and placebo and will dispense the study drug according to treatment allocation. Treatment allocation will remain concealed from all other investigators involved in the conduct and analysis of the trial. All other medical staff involved in patient care during the hospital stay of study participant and the study participants itself along with guardians will be also blinded throughout.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

June 28, 2021

First Posted

July 13, 2021

Study Start

June 1, 2021

Primary Completion

April 15, 2022

Study Completion

April 22, 2022

Last Updated

December 28, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations